[ Price : $8.95]
FDA grants Aridis Pharmaceuticals a fast track designation for AR-301, a fully human anti-Staphylococcal alpha-toxin IgG1 monoclon...[ Price : $8.95]
FDA grants fast track designation to MediciNova for its MN-001 (tipelukast) for treating patients with idiopathic pulmonary fibros...[ Price : $8.95]
FDA accepts for review a Theravance Biopharma supplemental NDA for Vibativ (telavancin) seeking to expand the current label to inc...[ Price : $8.95]
Novo Nordisk announce a research collaboration with Langer Laboratory at the Massachusetts Institute of Technology to develop the ...[ Price : $8.95]
FDA grants BioCancell a fast track designation for BC-819 and its use in treating bladder cancer patients.[ Price : $8.95]
FDA revises labeling for Janssens diabetes drug Invokana (canaglifozin) to explain an increased risk of bone fracture and reduced ...[ Price : $8.95]
FDA accepts for review a Teva Pharmaceutical Industries supplemental NDA for ProAir RespiClick (albuterol sulfate) Inhalation Powd...[ Price : $8.95]
FDA accepts for review a Wellstat Therapeutics NDA for its investigational drug uridine triacetate, indicated as an antidote for p...